APA (7th ed.) Citation

Tsai, Y., Wu, C., Li, C., Shih, C., Chang, Y., Hwang, J., & Tai, T. (2023). Drug adherence and treatment duration for denosumab and mortality risk among hip fracture patients. Osteoporosis international, 34(10), 1783-1791. https://doi.org/10.1007/s00198-023-06845-0

Chicago Style (17th ed.) Citation

Tsai, Yi-Lun, Chih-Hsing Wu, Chia-Chun Li, Chien-An Shih, Yin-Fan Chang, Jawl-Shan Hwang, and Ta-Wei Tai. "Drug Adherence and Treatment Duration for Denosumab and Mortality Risk Among Hip Fracture Patients." Osteoporosis International 34, no. 10 (2023): 1783-1791. https://doi.org/10.1007/s00198-023-06845-0.

MLA (9th ed.) Citation

Tsai, Yi-Lun, et al. "Drug Adherence and Treatment Duration for Denosumab and Mortality Risk Among Hip Fracture Patients." Osteoporosis International, vol. 34, no. 10, 2023, pp. 1783-1791, https://doi.org/10.1007/s00198-023-06845-0.